MO
Moberg Pharma AB (publ)
MOB.ST · STO
11.30 kr -1.57% (-0.18 kr)
1M +3.29%
Market Cap 541.6M kr
P/E Ratio -
Div. Yield -
ROE 3.24%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
50 /100
Fair P/S 32.31x
P/B 0.82x
P/E N/A
Growth
92 /100
Growing Rev. growth 302.90%
Book val. growth 7.63%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 62.31%
Net margin 128.96%
Op. margin 149.56%
Quality
0 /100
Poor ROIC 4.98%
ROE 3.24%
ROA 3.17%
Debt
69 /100
Low Debt/Equity 0.00x
Current ratio 12.25x
Int. coverage -175.39x
Stability
37 /100
Moderate Beta 0.74x
EPS volatility 265.92%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MOB.ST
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Anna Ljung
Employees
5
Headquarters
Bromma
Upcoming events
12 NOV
Earnings
Upcoming earnings report